MicroStrategy may soon enter the Nasdaq 100, replacing Moderna. This move is driven by MicroStrategy's significant Bitcoin holdings and stock market growth. The prediction comes from respected ETF analysts Eric Balchunas and James Seyffart, with the announcement expected by the end of the week if approved. MicroStrategy's classification as a tech stock and its eligibility for the finance category are key considerations. #MicroStrategy #Nasdaq100 #Bitcoin #ETF #StockMarket